SAREPTA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.08 BRL | -0.05% |
|
+33.09% | +87.63% |
| 06-26 | Monetary policy is getting even more confusing |  |
| 06-26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Bio Therapeutic Drugs | -0.05% | +33.09% | +87.63% | +59.26% | - | 14.83B | - | - | - |
